Correspondence 0001213900-24-065135 from Inmune Bio, Inc. (INMB) (CIK 0001711754) (INMB)
Inmune Bio, Inc. (INMB) (CIK 0001711754)
Date: Aug. 5, 2024 · CIK: 0001711754 · Accession: 0001213900-24-065135
AI Filing Summary & Sentiment
File numbers found in text: 333-279036
Show Raw Text
CORRESP
1
filename1.htm
INmune
Bio Inc.
225
NE Mizner Blvd., Suite 640
Boca
Raton, Florida 33432
(858)-964-3720
August
5, 2024
VIA
EDGAR
United
States Securities and Exchange Commission
Division
of Corporation Finance
100
F. Street, N.E.
Washington,
D.C. 20549
Re:
INmune Bio Inc.
Registration
Statement on Form S-3
File
No. 333-279036
Ladies
and Gentlemen:
Pursuant
to Rule 461 promulgated under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for
the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 p.m., Eastern Time on August
7, 2024, or as soon thereafter as practicable.
Please
contact Christian Lichtenberger, Esq. of Sichenzia Ross Ference Carmel LLP at (646)-810-0591, as soon as the Registration Statement has
been declared effective, or if you have any other questions or concerns regarding this matter.
Very
truly yours,
INMUNE
BIO INC.
By:
/s/
David Moss
David
Moss
Chief
Financial Officer